Emergent Biosolutions(EBS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

EBS Emergent Biosolutions

休市中 11-06 16:00:00 EST

6.06

+0.21

+3.59%

盘后5.97

-0.09-1.49%

19:30 EST

最高6.07	最低5.78	成交量100.43万
今开5.79	昨收5.85	日振幅5.04%
总市值3.11亿	流通市值2.93亿	总股本5,127万
成交额597.84万	换手率2.08%	流通股本4,837万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"EBS","market":"US","secType":"STK","nameCN":"Emergent Biosolutions","latestPrice":6.06,"timestamp":1793998800000,"preClose":5.85,"halted":0,"volume":1004275,"hourTrading":{"tag":"盘后","latestPrice":5.97,"preClose":6.06,"latestTime":"19:30 EST","volume":13077,"amount":79224.7406,"timestamp":1794011408294,"change":-0.09,"changeRate":-0.014851,"amplitude":0.014851},"delay":0,"changeRate":0.035897435897435895,"floatShares":48372666,"shares":51273336,"eps":-5.035248,"marketStatus":"休市中","change":0.21,"latestTime":"11-06 16:00:00 EST","open":5.79,"high":6.07,"low":5.775,"amount":5978374.457367499,"amplitude":0.050427,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-5.035248,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1794214800000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1254456000000,"exchange":"NYSE","adjPreClose":5.85,"preHourTrading":{"tag":"盘前","latestPrice":5.72,"preClose":5.85,"latestTime":"08:46 EST","volume":715,"amount":4113.7999045,"timestamp":1793972799461,"change":-0.13,"changeRate":-0.022222,"amplitude":0.217094},"postHourTrading":{"tag":"盘后","latestPrice":5.97,"preClose":6.06,"latestTime":"19:30 EST","volume":13077,"amount":79224.7406,"timestamp":1794011408294,"change":-0.09,"changeRate":-0.014851,"amplitude":0.014851},"volumeRatio":0.5789764792339323,"impliedVol":0.9353,"impliedVolPercentile":0.7689},"requestUrl":"/m/hq/s/EBS","defaultTab":"news","newsList":[{"id":"2676663054","title":"芝商所正调查欧洲、中东和非洲地区EBS工作站的下单问题。","url":"https://stock-news.laohu8.com/highlight/detail?id=2676663054","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676663054?lang=zh_cn&edition=full","pubTime":"2026-10-20 16:26","pubTimestamp":1792484813,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4139","EBS","BK4583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178687061","title":"Emergent BioSolutions圆满完成7500万美元优先无担保票据回购","url":"https://stock-news.laohu8.com/highlight/detail?id=1178687061","media":"美股速递","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1178687061?lang=zh_cn&edition=full","pubTime":"2026-09-03 19:49","pubTimestamp":1788436160,"startTime":"0","endTime":"0","summary":"Emergent BioSolutions（EBS）今日宣布，已顺利完成总额达7500万美元的优先无担保票据回购计划。这一财务操作标志着该公司在优化资本结构方面迈出了坚实一步。此次回购涉及的是公司此前发行的优先无担保债券，其回购价格及相关条款均符合市场惯例与公司既定策略。通过此举，Emergent BioSolutions不仅有效降低了未来的利息负担，还进一步增强了资产负债表的灵活性。该公司管理层表示，此次回购体现了其对股东价值创造的持续承诺，未来将继续审慎评估各类资本配置机会，以支持核心业务的长期增长与创新。分析人士认为，此举或将对公司短期财务指标产生积极影响，并提升投资者信心。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EBS","BK4583","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149776488","title":"Emergent BioSolutions获增购Cyfendus（Av7909）合同修订——SEC文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1149776488","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1149776488?lang=zh_cn&edition=full","pubTime":"2026-09-02 04:15","pubTimestamp":1788293710,"startTime":"0","endTime":"0","summary":"Emergent BioSolutions（纽交所代码：EBS）于近日向美国证券交易委员会（SEC）提交了一份文件，披露其合同修订情况。\n该修订涉及该公司旗下炭疽疫苗产品Cyfendus（Av7909）的额外采购。根据修订条款，采购方将在原有基础上追加订购更多剂量的Cyfendus。\n这笔增购交易的具体金额和交付时间表尚未在文件中详细披露。公司方面表示，此次合同修改反映了采购方对该疫苗产品的持续需求。\n文件提交后，市场对此消息暂无重大反应。Emergent BioSolutions是一家专注于公共卫生防护领域的生物制药公司，其产品线涵盖炭疽、天花等生物威胁相关疫苗及治疗药物。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","EBS","BK4583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143626034","title":"Emergent BioSolutions 获得长期供应合同：有效期至2029年，附两年续约选择权","url":"https://stock-news.laohu8.com/highlight/detail?id=1143626034","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1143626034?lang=zh_cn&edition=full","pubTime":"2026-08-31 19:56","pubTimestamp":1788177374,"startTime":"0","endTime":"0","summary":"Emergent BioSolutions宣布，其长期供应协议自2026年10月1日起正式生效，并将持续至2029年9月30日。这份合同还附带了一项重要条款——在现有期限届满后，可选择续约两年。此举无疑为该公司未来的业务稳定性提供了坚实保障。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","EBS","BK4583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518822412","title":"Emergent Biosolutions Inc.盘中异动 早盘快速下跌5.20%报5.47美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518822412","media":"市场透视","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518822412?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:35","pubTimestamp":1741613729,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时35分，Emergent Biosolutions Inc.股票出现波动，股价大幅跳水5.20%。截至发稿，该股报5.47美元/股，成交量5.3544万股，换手率0.10%，振幅1.56%。Emergent Biosolutions Inc.股票所在的制药行业中，整体跌幅为0.64%。其相关个股中，Sonoma Pharmaceuticals, Inc.、Alpha Teknova, Inc.、Flora Growth Corp.涨幅较大，Sonoma Pharmaceuticals, Inc.、Petros Pharmaceuticals, Inc.、苏轩堂较为活跃，换手率分别为52.14%、8.77%、2.85%，振幅较大的相关个股有Shuttle Pharmaceuticals Holdings, Inc.、惠普森医药、Alpha Teknova, Inc.，振幅分别为13.84%、12.67%、12.14%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213529a26a2645&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213529a26a2645&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4583","EBS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516677553","title":"Emergent Biosolutions Inc.股价重挫15.96% 市值跌4963.83万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516677553","media":"市场透视","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516677553?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:32","pubTimestamp":1741098779,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时32分，Emergent Biosolutions Inc.股票出现异动，股价快速下跌15.96%。截至发稿，该股报5.74美元/股，成交量35.3898万股，换手率0.65%，振幅4.39%。Emergent Biosolutions Inc.股票所在的制药行业中，整体跌幅为0.02%。Emergent Biosolutions Inc.公司简介：Emergent BioSolutions Inc 向政府和医疗保健提供者提供公共卫生产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223259abe7f004&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223259abe7f004&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","EBS","BK4583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516966912","title":"Emergent BioSolutions(EBS.US)：2024年Q4财报实现营收1.947亿美元，前值为2.766亿美元，预期值为2.547亿美元；每股收益为0.05美元，前值为-0.77美元，预期值为-0.50美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2516966912","media":"金融界","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516966912?lang=zh_cn&edition=full","pubTime":"2025-03-04 05:32","pubTimestamp":1741037576,"startTime":"0","endTime":"0","summary":"Emergent BioSolutions(EBS.US)：2024年Q4财报实现营收1.947亿美元，前值为2.766亿美元，预期值为2.547亿美元；每股收益为0.05美元，前值为-0.77美元，预期值为-0.50美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/04053248499197.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["EBS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1101283831","title":"Emergent BioSolutions第四季度调整后每股收益$0.05，超出预期$(0.49)，销售额$194.70M不及预期$254.67M","url":"https://stock-news.laohu8.com/highlight/detail?id=1101283831","media":"财报速递","labels":["merge","express"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1101283831?lang=zh_cn&edition=full","pubTime":"2025-03-04 05:31","pubTimestamp":1741037470,"startTime":"0","endTime":"0","summary":"Emergent BioSolutions报告的季度每股收益为$0.05，比分析师预期的$高出110.2%。公司报告的季度销售额为$194.70M，不及分析师预期的$254.67M，低23.55%。这比去年同期的销售额$276.60M减少了29.61%。以上内容来自Benzinga Earnings专栏，原文如下：Emergent BioSolutions  reported quarterly earnings of $0.05 per share which beat the analyst consensus estimate of $ by 110.2 percent. This is a 106.49 percent increase over losses of $ per share from the same period last year.  The company reported quarterly sales of $194.70 million which missed the analyst consensus estimate of $254.67 mi","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Emergent BioSolutions第四季度调整后每股收益$0.05，超出预期$(0.49)，销售额$194.70M不及预期$254.67M","news_tag":"merge,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EBS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516765030","title":"Emergent Biosolutions Inc.盘中异动 下午盘股价大跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516765030","media":"市场透视","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516765030?lang=zh_cn&edition=full","pubTime":"2025-03-04 03:28","pubTimestamp":1741030121,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日03时28分，Emergent Biosolutions Inc.股票出现异动，股价快速下跌5.01%。截至发稿，该股报7.11美元/股，成交量86.0413万股，换手率1.59%，振幅6.63%。Emergent Biosolutions Inc.股票所在的制药行业中，整体涨幅为1.03%。Emergent Biosolutions Inc.公司简介：Emergent BioSolutions Inc 向政府和医疗保健提供者提供公共卫生产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304032841a25d920f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304032841a25d920f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4583","EBS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516237176","title":"Emergent Biosolutions Inc.盘中异动 临近午盘股价大涨5.10%报7.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516237176","media":"市场透视","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516237176?lang=zh_cn&edition=full","pubTime":"2025-03-01 00:48","pubTimestamp":1740761281,"startTime":"0","endTime":"0","summary":"北京时间2025年03月01日00时48分，Emergent Biosolutions Inc.股票出现异动，股价快速拉升5.10%。截至发稿，该股报7.42美元/股，成交量25.5917万股，换手率0.47%，振幅6.37%。Emergent Biosolutions Inc.股票所在的制药行业中，整体跌幅为0.10%。Emergent Biosolutions Inc.公司简介：Emergent BioSolutions Inc 向政府和医疗保健提供者提供公共卫生产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503010048019634390c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503010048019634390c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4583","EBS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513781327","title":"Emergent Biosolutions Inc.盘中异动 急速跳水5.19%报7.31美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513781327","media":"市场透视","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513781327?lang=zh_cn&edition=full","pubTime":"2025-02-24 23:28","pubTimestamp":1740410881,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日23时28分，Emergent Biosolutions Inc.股票出现异动，股价大幅下挫5.19%。截至发稿，该股报7.31美元/股，成交量32.9475万股，换手率0.61%，振幅4.86%。Emergent Biosolutions Inc.股票所在的制药行业中，整体涨幅为0.75%。Emergent Biosolutions Inc.公司简介：Emergent BioSolutions Inc 向政府和医疗保健提供者提供公共卫生产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502242328039891035c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502242328039891035c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4583","BK4139","EBS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512489924","title":"Emergent Biosolutions Inc.盘中异动 大幅下跌5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512489924","media":"市场透视","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512489924?lang=zh_cn&edition=full","pubTime":"2025-02-19 23:31","pubTimestamp":1739979095,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日23时31分，Emergent Biosolutions Inc.股票出现异动，股价急速下跌5.16%。截至发稿，该股报7.91美元/股，成交量48.0852万股，换手率0.89%，振幅4.44%。Emergent Biosolutions Inc.股票所在的制药行业中，整体涨幅为0.87%。其相关个股中，坎伯兰药业、Gelteq Limited、和黄医药涨幅较大，Petros Pharmaceuticals, Inc.、Painreform Ltd.、大自然药业较为活跃，换手率分别为36.19%、29.93%、8.63%，振幅较大的相关个股有坎伯兰药业、Painreform Ltd.、Medicus Pharma Ltd.，振幅分别为12.24%、10.24%、9.60%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219233135a24c07b1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219233135a24c07b1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","EBS","BK4583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512193283","title":"Emergent Biosolutions Inc.盘中异动 下午盘大幅跳水5.14%报9.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512193283","media":"市场透视","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512193283?lang=zh_cn&edition=full","pubTime":"2025-02-19 02:14","pubTimestamp":1739902489,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日02时14分，Emergent Biosolutions Inc.股票出现异动，股价快速下挫5.14%。截至发稿，该股报9.22美元/股，成交量49.1939万股，换手率0.91%，振幅6.77%。Emergent Biosolutions Inc.股票所在的制药行业中，整体涨幅为1.91%。其相关个股中，Painreform Ltd.、Flora Growth Corp.、Indivior Plc涨幅较大，Painreform Ltd.、Petros Pharmaceuticals, Inc.、Cbdmd, Inc.较为活跃，换手率分别为4824.40%、234.00%、12.63%，振幅较大的相关个股有Painreform Ltd.、Cyclo Therapeutics Inc C/Wts 11/12/2025、Sunshine Biopharma Inc C/Wts ，振幅分别为74.44%、35.46%、25.64%。Emergent Biosolutions Inc.公司简介：Emergent BioSolutions Inc 向政府和医疗保健提供者提供公共卫生产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219021449a24adb7c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219021449a24adb7c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4583","EBS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510300913","title":"Emergent Biosolutions Inc.盘中异动 大幅下跌5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510300913","media":"市场透视","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510300913?lang=zh_cn&edition=full","pubTime":"2025-02-12 01:46","pubTimestamp":1739296006,"startTime":"0","endTime":"0","summary":"北京时间2025年02月12日01时46分，Emergent Biosolutions Inc.股票出现波动，股价快速下挫5.14%。截至发稿，该股报9.59美元/股，成交量46.3047万股，换手率0.85%，振幅5.19%。Emergent Biosolutions Inc.股票所在的制药行业中，整体跌幅为0.04%。其相关个股中，Scilex Holding Company C/Wts 10/11/2027 、Cyclo Therapeutics Inc C/Wts 11/12/2025、坎伯兰药业涨幅较大，大自然药业、Quantum Biopharma Ltd.、Cbdmd, Inc.较为活跃，换手率分别为33.46%、26.74%、7.09%，振幅较大的相关个股有Cyclo Therapeutics Inc C/Wts 11/12/2025、Quantum Biopharma Ltd.、Alvotech C/Wts ，振幅分别为20.30%、17.55%、15.91%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250212014647abcb2fff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250212014647abcb2fff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4583","EBS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509773574","title":"Emergent Biosolutions Inc.盘中异动 股价大跌5.16%报9.92美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509773574","media":"市场透视","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509773574?lang=zh_cn&edition=full","pubTime":"2025-02-08 03:27","pubTimestamp":1738956457,"startTime":"0","endTime":"0","summary":"北京时间2025年02月08日03时27分，Emergent Biosolutions Inc.股票出现波动，股价快速下跌5.16%。截至发稿，该股报9.92美元/股，成交量51.1397万股，换手率0.94%，振幅5.64%。Emergent Biosolutions Inc.股票所在的制药行业中，整体涨幅为0.55%。Emergent Biosolutions Inc.公司简介：Emergent BioSolutions Inc 向政府和医疗保健提供者提供公共卫生产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208032737987ddf5b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208032737987ddf5b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4583","EBS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508149777","title":"Emergent Biosolutions Inc.盘中异动 快速跳水8.03%报10.35美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508149777","media":"市场透视","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508149777?lang=zh_cn&edition=full","pubTime":"2025-02-03 22:35","pubTimestamp":1738593312,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时35分，Emergent Biosolutions Inc.股票出现异动，股价急速下挫8.03%。截至发稿，该股报10.35美元/股，成交量18.2814万股，换手率0.34%，振幅3.45%。Emergent Biosolutions Inc.股票所在的制药行业中，整体跌幅为0.13%。其相关个股中，Medicus Pharma Ltd.、脑再生科技、Incannex Healthcare Inc.涨幅较大，Inmed Pharmaceuticals Inc.、Painreform Ltd.、苏轩堂较为活跃，换手率分别为29.19%、4.18%、1.59%，振幅较大的相关个股有Ironwood医药、Procaps Group, S.A.、Canopy Growth Corporation，振幅分别为6.84%、5.66%、5.53%。Emergent Biosolutions Inc.公司简介：Emergent BioSolutions Inc 向政府和医疗保健提供者提供公共卫生产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203223512a2380a79&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203223512a2380a79&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","EBS","BK4583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507707286","title":"Emergent Biosolutions Inc.盘中异动 急速拉升5.00%报11.34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507707286","media":"市场透视","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2507707286?lang=zh_cn&edition=full","pubTime":"2025-01-31 04:34","pubTimestamp":1738269265,"startTime":"0","endTime":"0","summary":"北京时间2025年01月31日04时34分，Emergent Biosolutions Inc.股票出现波动，股价大幅拉升5.00%。截至发稿，该股报11.34美元/股，成交量44.7062万股，换手率0.83%，振幅3.89%。Emergent Biosolutions Inc.股票所在的制药行业中，整体涨幅为1.72%。Emergent Biosolutions Inc.公司简介：Emergent BioSolutions Inc 向政府和医疗保健提供者提供公共卫生产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025013104342596146542&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025013104342596146542&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4583","BK4139","EBS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2506588712","title":"Emergent Biosolutions Inc.盘中异动 股价大跌5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2506588712","media":"市场透视","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2506588712?lang=zh_cn&edition=full","pubTime":"2025-01-28 01:56","pubTimestamp":1738000613,"startTime":"0","endTime":"0","summary":"北京时间2025年01月28日01时56分，Emergent Biosolutions Inc.股票出现异动，股价大幅下跌5.06%。截至发稿，该股报11.07美元/股，成交量32.412万股，换手率0.60%，振幅4.97%。Emergent Biosolutions Inc.股票所在的制药行业中，整体涨幅为2.33%。Emergent Biosolutions Inc.公司简介：Emergent BioSolutions Inc 向政府和医疗保健提供者提供公共卫生产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501280156549874ceb9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501280156549874ceb9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EBS","BK4139","BK4583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505032887","title":"存制动助力失效问题，上汽通用五菱召回部分宝骏悦也汽车","url":"https://stock-news.laohu8.com/highlight/detail?id=2505032887","media":"IT之家","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505032887?lang=zh_cn&edition=full","pubTime":"2025-01-24 15:57","pubTimestamp":1737705467,"startTime":"0","endTime":"0","summary":"IT之家 1 月 24 日消息，IT之家从国家市场监督管理总局获悉，日前，上汽通用五菱汽车股份有限公司根据《缺陷汽车产品召回管理条例》和《缺陷汽车产品召回管理条例实施办法》的要求，向国家市场监督管理总局备案了召回计划。决定自即日起，召回 2023 年 4 月 20 日至 2023 年 6 月 14 日期间生产的部分宝骏悦也汽车，共计 1116 辆。上汽通用五菱汽车股份有限公司将为召回范围内的车辆升级 EBS 软件，以消除安全隐患。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://tech.ifeng.com/c/8gPDlDRUYE5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"ifeng_tech","symbols":["BK4583","BK4139","EBS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505011645","title":"Emergent Biosolutions Inc.盘中异动 早盘急速拉升5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505011645","media":"市场透视","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505011645?lang=zh_cn&edition=full","pubTime":"2025-01-23 22:32","pubTimestamp":1737642732,"startTime":"0","endTime":"0","summary":"北京时间2025年01月23日22时32分，Emergent Biosolutions Inc.股票出现异动，股价大幅上涨5.05%。截至发稿，该股报11.42美元/股，成交量9.5287万股，换手率0.18%，振幅5.03%。Emergent Biosolutions Inc.股票所在的制药行业中，整体跌幅为0.30%。其相关个股中，Evoke Pharma, Inc.、Petros Pharmaceuticals, Inc.、Emergent Biosolutions Inc.涨幅较大，Inmed Pharmaceuticals Inc.、Incannex Healthcare Inc.、Painreform Ltd.较为活跃，换手率分别为7.75%、7.05%、1.26%，振幅较大的相关个股有Inmed Pharmaceuticals Inc.、惠普森医药、Incannex Healthcare Inc.，振幅分别为6.25%、5.81%、5.30%。Emergent Biosolutions Inc.公司简介：Emergent BioSolutions Inc 向政府和医疗保健提供者提供公共卫生产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123223213abb5fac2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123223213abb5fac2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","EBS","BK4583"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.emergentbiosolutions.com","stockEarnings":[{"period":"1week","weight":-0.1101},{"period":"1month","weight":-0.1429},{"period":"3month","weight":0.2521},{"period":"6month","weight":-0.3621},{"period":"1year","weight":-0.4099},{"period":"ytd","weight":-0.5097}],"compareEarnings":[{"period":"1week","weight":-0.027},{"period":"1month","weight":-0.0539},{"period":"3month","weight":-0.0491},{"period":"6month","weight":-0.0032},{"period":"1year","weight":0.0969},{"period":"ytd","weight":0.0783}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Emergent Biosolutions Inc.于1998年5月在美国密歇根州成立，随后在 2004年6月改为特拉华公司。公司拥有两个经营部门：生物防卫和生物科学。该公司是一家全球性生命科学公司，专注于提供创新的准备和响应解决方案，以应对意外、故意和自然发生的公共健康威胁。","yearOnYearQuotes":[{"month":1,"riseRate":0.7,"avgChangeRate":0.042008},{"month":2,"riseRate":0.4,"avgChangeRate":-0.01419},{"month":3,"riseRate":0.45,"avgChangeRate":-0.032712},{"month":4,"riseRate":0.45,"avgChangeRate":-0.034251},{"month":5,"riseRate":0.6,"avgChangeRate":0.111052},{"month":6,"riseRate":0.6,"avgChangeRate":0.007243},{"month":7,"riseRate":0.55,"avgChangeRate":0.094079},{"month":8,"riseRate":0.45,"avgChangeRate":-0.024659},{"month":9,"riseRate":0.4,"avgChangeRate":-0.028687},{"month":10,"riseRate":0.6,"avgChangeRate":0.029695},{"month":11,"riseRate":0.55,"avgChangeRate":-0.007544},{"month":12,"riseRate":0.6,"avgChangeRate":0.044099}],"exchange":"NYSE","name":"Emergent Biosolutions","nameEN":"Emergent BioSolutions"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Emergent Biosolutions(EBS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Emergent Biosolutions(EBS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Emergent Biosolutions,EBS,Emergent Biosolutions股票,Emergent Biosolutions股票老虎,Emergent Biosolutions股票老虎国际,Emergent Biosolutions行情,Emergent Biosolutions股票行情,Emergent Biosolutions股价,Emergent Biosolutions股市,Emergent Biosolutions股票价格,Emergent Biosolutions股票交易,Emergent Biosolutions股票购买,Emergent Biosolutions股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Emergent Biosolutions(EBS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Emergent Biosolutions(EBS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}